IL216954A - Refolding proteins using a chemically controlled redox state - Google Patents
Refolding proteins using a chemically controlled redox stateInfo
- Publication number
- IL216954A IL216954A IL216954A IL21695411A IL216954A IL 216954 A IL216954 A IL 216954A IL 216954 A IL216954 A IL 216954A IL 21695411 A IL21695411 A IL 21695411A IL 216954 A IL216954 A IL 216954A
- Authority
- IL
- Israel
- Prior art keywords
- redox state
- refolding proteins
- chemically controlled
- controlled redox
- chemically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21925709P | 2009-06-22 | 2009-06-22 | |
| PCT/US2010/039390 WO2011005488A1 (en) | 2009-06-22 | 2010-06-21 | Refolding proteins using a chemically controlled redox state |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL216954A0 IL216954A0 (en) | 2012-02-29 |
| IL216954A true IL216954A (en) | 2016-09-29 |
Family
ID=42710673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL216954A IL216954A (en) | 2009-06-22 | 2011-12-13 | Refolding proteins using a chemically controlled redox state |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US8952138B2 (en) |
| EP (2) | EP3366692A1 (en) |
| JP (2) | JP5808323B2 (en) |
| KR (1) | KR101741859B1 (en) |
| CN (1) | CN102482321B (en) |
| AU (1) | AU2010270986B2 (en) |
| BR (1) | BRPI1011940B8 (en) |
| CA (1) | CA2765881C (en) |
| CL (1) | CL2011003278A1 (en) |
| EA (1) | EA020621B1 (en) |
| IL (1) | IL216954A (en) |
| MX (1) | MX2011013898A (en) |
| SG (1) | SG176963A1 (en) |
| WO (1) | WO2011005488A1 (en) |
| ZA (1) | ZA201200512B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3366692A1 (en) * | 2009-06-22 | 2018-08-29 | Amgen, Inc | Refolding proteins using a chemically controlled redox state |
| MX2011013417A (en) | 2009-06-25 | 2012-03-29 | Amgen Inc | Capture purification processes for proteins expressed in a non-mammalian system. |
| EP2417982A1 (en) * | 2010-07-30 | 2012-02-15 | Ferring B.V. | Stabilization of gonadotropins |
| WO2014128726A2 (en) * | 2013-02-22 | 2014-08-28 | Biogenomics Limited | Process for high efficiency refolding of recombinant proteins |
| US10633414B2 (en) * | 2015-07-27 | 2020-04-28 | Purdue Research Foundation | Tandem folding methods to improve protein folding yield |
| EP3344651B1 (en) | 2015-09-02 | 2022-03-02 | Merck Sharp & Dohme Corp. | A process for obtaining insulin with correctly formed disulfide bonds |
| KR102435801B1 (en) | 2016-07-22 | 2022-08-25 | 암젠 인크 | Methods for Purification of FC-Containing Proteins |
| CN108276470A (en) * | 2017-01-06 | 2018-07-13 | 深圳市新产业生物医学工程股份有限公司 | Cell pyrolysis liquid, the method for extracting intracellular protein, the method and kit for preparing toxoplasma antigen |
| WO2018190301A1 (en) * | 2017-04-10 | 2018-10-18 | 花王株式会社 | Keratin plug removal method |
| WO2019183334A1 (en) | 2018-03-21 | 2019-09-26 | Waters Technologies Corporation | Non-antibody high-affinity-based sample preparation, sorbents, devices and methods |
| CN113423722A (en) * | 2018-11-07 | 2021-09-21 | 应用分子运输公司 | Delivery constructs for transcytosis and related methods |
| US20240101598A1 (en) | 2020-12-18 | 2024-03-28 | Richter Gedeon Nyrt. | Methods for the purification of refolded fc-peptide fusion protein |
| CN115894604B (en) * | 2022-12-16 | 2024-01-23 | 康日百奥生物科技(苏州)有限公司 | Recombinant protein clarifying and purifying method |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4237224A (en) | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
| US4468464A (en) | 1974-11-04 | 1984-08-28 | The Board Of Trustees Of The Leland Stanford Junior University | Biologically functional molecular chimeras |
| DE122080T1 (en) | 1983-03-25 | 1985-05-23 | Celltech Ltd., Slough, Berkshire | METHOD FOR PRODUCING A PROTEIN. |
| US4468454A (en) | 1983-06-10 | 1984-08-28 | E. I. Du Pont De Nemours And Company | Antifoggant process |
| US4572798A (en) * | 1984-12-06 | 1986-02-25 | Cetus Corporation | Method for promoting disulfide bond formation in recombinant proteins |
| US4810643A (en) | 1985-08-23 | 1989-03-07 | Kirin- Amgen Inc. | Production of pluripotent granulocyte colony-stimulating factor |
| IL86090A (en) | 1987-04-16 | 1993-03-15 | Cetus Oncology Corp | Production of purified, biologically active, bacterially produced recombinant human csf-1 |
| GB8807673D0 (en) | 1988-03-31 | 1988-05-05 | Lingner & Fischer Gmbh | Novel article |
| EP0719860B1 (en) | 1988-05-13 | 2009-12-16 | Amgen Inc. | Process for isolating and purifying G-CSF |
| GB8927546D0 (en) * | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
| DE69129747T2 (en) * | 1990-09-05 | 1998-11-12 | Southern Cross Biotech Pty Ltd | BRINGING PROTEINS IN SOLUTION IN ACTIVE FORM |
| WO1993018136A1 (en) | 1992-03-05 | 1993-09-16 | Cytomed, Inc. | Process for supporting hematopoietic progenitor cells |
| US5663304A (en) | 1993-08-20 | 1997-09-02 | Genentech, Inc. | Refolding of misfolded insulin-like growth factor-I |
| ATE147753T1 (en) | 1993-11-10 | 1997-02-15 | Pfizer | PROCESS FOR REFOLDING (PRO-)CHYMOSIN, WITH RECIRCULATION OF UREA |
| US5466377A (en) | 1994-01-19 | 1995-11-14 | Grandics; Peter | Chromatography media and their uses |
| WO1995032216A1 (en) * | 1994-05-25 | 1995-11-30 | University Of Nebraska Board Of Regents | Biologically active glycoprotein hormones produced in procaryotic cells |
| EP0832220A1 (en) | 1995-06-07 | 1998-04-01 | Amgen Inc. | Ob protein compositions and method |
| US5935824A (en) | 1996-01-31 | 1999-08-10 | Technologene, Inc. | Protein expression system |
| US6653098B1 (en) * | 1998-02-23 | 2003-11-25 | G. D. Searle & Co. | Method of producing mouse and human endostatin |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| DE60024997T2 (en) | 1999-07-21 | 2006-08-24 | Amgen Inc., Thousand Oaks | VGF POLYPEPTIDES AND METHOD FOR THE TREATMENT OF VGF DISEASES |
| US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| AU7485301A (en) | 2000-05-16 | 2001-11-26 | Bolder Biotechnology Inc | Methods for refolding proteins containing free cysteine residues |
| AU2001288812B2 (en) | 2000-09-05 | 2007-05-10 | Amgen Inc. | TNF receptor-like molecules and uses thereof |
| US7157557B2 (en) | 2001-02-23 | 2007-01-02 | Immunex Corporation | Increased recovery of active proteins |
| US6972327B1 (en) | 2001-05-08 | 2005-12-06 | Immunex Corporation | Regeneration of chromatography material |
| US7138370B2 (en) | 2001-10-11 | 2006-11-21 | Amgen Inc. | Specific binding agents of human angiopoietin-2 |
| AU2002345829A1 (en) | 2002-06-24 | 2004-01-06 | Dr. Reddy's Laboratories Ltd. | Process for preparing g-csf |
| ES2359562T3 (en) * | 2002-12-20 | 2011-05-24 | Amgen, Inc. | UNION AGENTS WHO INHIBIT MYOSTATINE. |
| EP1449848A1 (en) | 2003-02-20 | 2004-08-25 | GBF German Research Centre for Biotechnology | Method for the production of cystine-knot proteins |
| US20050209441A1 (en) | 2004-03-22 | 2005-09-22 | Lile Jackson D | Process for promoting proper folding of human serum albumin using a human serum albumin ligand |
| FR2874318B1 (en) | 2004-08-19 | 2006-11-24 | Oreal | USE IN COSMETICS OF AMPHOTERIC POLYMERIC COMPOUNDS WITH CATIONIC (S) POLYMERIC (S) STRING (S) |
| CA2580796C (en) | 2004-09-24 | 2013-03-26 | Amgen Inc. | Modified fc molecules having peptides inserted in internal loop regions |
| US7435804B2 (en) | 2004-10-19 | 2008-10-14 | Phage Biotechnology, Inc. | Method for obtaining single chain antibodies to human interferon α2b |
| EA012162B1 (en) | 2004-10-22 | 2009-08-28 | Эмджен Инк. | Methods for refolding of recombinant antibodies |
| JP2008528039A (en) | 2005-01-28 | 2008-07-31 | ザイモジェネティクス，インコーポレイティド | Homogeneous preparation of IL-31 |
| DE102005033250A1 (en) | 2005-07-15 | 2007-01-18 | Bioceuticals Arzneimittel Ag | Process for purifying G-CSF |
| WO2007130154A2 (en) | 2005-12-22 | 2007-11-15 | Genentech, Inc. | Recombinant production of heparin binding proteins |
| US7612273B2 (en) * | 2006-03-20 | 2009-11-03 | Roland Corporation | Electronic percussion instrument |
| EP1845103B1 (en) * | 2006-04-10 | 2015-02-25 | Boehringer Ingelheim RCV GmbH & Co KG | Method for refolding a protein |
| CN101506222B (en) | 2006-07-14 | 2013-10-02 | 健泰科生物技术公司 | Refolding of recombinant proteins |
| WO2008096370A2 (en) | 2007-02-05 | 2008-08-14 | Natco Pharma Limited | An efficient and novel purification method of recombinant hg-csf |
| US20080214795A1 (en) | 2007-02-14 | 2008-09-04 | Amgen Inc. | Method of isolating antibodies by precipitation |
| MX2010001684A (en) | 2007-08-15 | 2010-04-21 | Amunix Inc | Compositions and methods for modifying properties of biologically active polypeptides. |
| HUE032894T2 (en) | 2008-06-25 | 2017-11-28 | Esbatech Alcon Biomed Res Unit | Stable and soluble antibodies inhibiting vegf |
| EP3366692A1 (en) | 2009-06-22 | 2018-08-29 | Amgen, Inc | Refolding proteins using a chemically controlled redox state |
| MX2011013417A (en) * | 2009-06-25 | 2012-03-29 | Amgen Inc | Capture purification processes for proteins expressed in a non-mammalian system. |
| KR20150140294A (en) | 2013-03-15 | 2015-12-15 | 암젠 인코퍼레이티드 | Myostatin antagonism in human subjects |
-
2010
- 2010-06-21 EP EP18167168.6A patent/EP3366692A1/en active Pending
- 2010-06-21 CA CA2765881A patent/CA2765881C/en active Active
- 2010-06-21 BR BRPI1011940A patent/BRPI1011940B8/en active IP Right Grant
- 2010-06-21 SG SG2011095411A patent/SG176963A1/en unknown
- 2010-06-21 CN CN201080028756.7A patent/CN102482321B/en active Active
- 2010-06-21 WO PCT/US2010/039390 patent/WO2011005488A1/en active Application Filing
- 2010-06-21 EA EA201270015A patent/EA020621B1/en not_active IP Right Cessation
- 2010-06-21 EP EP10747092.4A patent/EP2445923B1/en active Active
- 2010-06-21 MX MX2011013898A patent/MX2011013898A/en active IP Right Grant
- 2010-06-21 AU AU2010270986A patent/AU2010270986B2/en active Active
- 2010-06-21 KR KR1020127001716A patent/KR101741859B1/en active IP Right Grant
- 2010-06-21 US US12/820,087 patent/US8952138B2/en active Active
- 2010-06-21 JP JP2012517634A patent/JP5808323B2/en active Active
-
2011
- 2011-12-13 IL IL216954A patent/IL216954A/en active IP Right Grant
- 2011-12-22 CL CL2011003278A patent/CL2011003278A1/en unknown
-
2012
- 2012-01-20 ZA ZA2012/00512A patent/ZA201200512B/en unknown
-
2015
- 2015-01-30 US US14/611,037 patent/US20150315232A1/en not_active Abandoned
- 2015-07-07 US US14/793,590 patent/US20150329586A1/en not_active Abandoned
- 2015-09-07 JP JP2015175422A patent/JP6026608B2/en active Active
-
2017
- 2017-02-01 US US15/422,327 patent/US9856287B2/en active Active
-
2018
- 2018-02-06 US US15/889,559 patent/US20190055281A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201200512B (en) | Refolding proteins using a chemically controlled redox state | |
| HK1218558A1 (en) | Mirac proteins mirac | |
| GB2478230B (en) | Gesture based edit mode | |
| EP2377028A4 (en) | Modifying commands | |
| EP2419120A4 (en) | Human protein scaffold with controlled serum pharmacokinetics | |
| HK1161275A1 (en) | Halogen-stabilized insulin | |
| HK1164489A1 (en) | Program shortcuts | |
| GB2475221B (en) | A book | |
| ZA201202266B (en) | Insecticidal proteins | |
| IL209167A0 (en) | Protein refolding method | |
| GB0918358D0 (en) | Wellbore completion | |
| GB0915235D0 (en) | Controlling a computer | |
| IL240134A0 (en) | Novel proteins | |
| GB0812019D0 (en) | Insulin | |
| GB0901271D0 (en) | Interface control | |
| TWI370607B (en) | Vibrator | |
| GB2500516B (en) | A book | |
| GB0903116D0 (en) | Content driven application state | |
| GB0914745D0 (en) | Portable spending control aid | |
| GB0911840D0 (en) | Control using movements | |
| GB201017532D0 (en) | Web book communicator & control | |
| GB0817560D0 (en) | Flick me | |
| GB0819392D0 (en) | Multifunctional pen | |
| ITRM20080048A1 (en) | REMOTE CONTROL INTERFACE | |
| AU325252S (en) | A truss spacer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |